NSTM — NovelStem International Corp.
—
OTC ·
Consumer Discretionary ·
Specialty Retail ·
CIK 912544 ·
Last close
$0.01
Market Cap
$493.3K
52W High
$0.02
52W Low
$0.01
ADV30
7,623
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -4,953 | -55,021 | 100,912 | 89,850 | 2,047,588 |
| Dec 2025 | 0 | — | -40,748 | -89,295 | 15,786 | 333 | 2,157,441 |
| Sep 2025 | 0 | — | -39,469 | -82,880 | 14,849 | 627 | 2,067,209 |
| Jun 2025 | 0 | — | -63,964 | 2,753,841 | 15,292 | 1,106 | 1,990,204 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-167,633
Investing CF
$0
Financing CF
$161,867
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.01
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-293,980,971
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$2,630,029
Pretax Income TTM
$2,373,810
Interest Exp TTM
$256,219
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -238,755 | 2,374,450 | 15,786 | 2,157,441 | — | -167,633 |
| Dec 2024 | 12,000 | -868,947 | -1,604,385 | 160,111 | 5,304,486 | — | -271,964 |
| Dec 2023 | 12,000 | -653,277 | -4,187,301 | 2,254,546 | 4,206,079 | — | -348,283 |
| Dec 2022 | 12,000 | -732,434 | -765,730 | 2,286,204 | 353,326 | — | -182,320 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RMTG | Regenerative Medical Technology Group Inc. | $478.8K | $0.04 | — |
| SNBH | SENTIENT BRANDS HOLDINGS INC. | $181.9K | $0.04 | — |
| JZXN | Jiuzi Holdings, Inc. | $1.48M | $1.11 | — |
| FBCD | FBC Holding, Inc. | $2.03M | $0.00 | — |
| JEM | 707 Cayman Holdings Ltd. | $2.13M | $1.51 | — |
Recent Insider Activity
No insider activity indexed for this ticker.